Related Experiment Video
Updated: Nov 24, 2025
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
20.2K
Update on Thrombocytopenia in Pregnancy.
Simone Filipa Carrasqueira Subtil1, Jorge Miguel Bastos Mendes1, Ana Luísa Fialho de Amaral Areia1
1Universidade de Coimbra, Coimbra, Portugal.
Summary
Thrombocytopenia in pregnancy affects 7-12% of cases. Differentiating mild gestational cases from severe conditions is crucial for appropriate maternal and fetal health management.
Area of Science:
- Obstetrics
- Hematology
- Perinatology
Background:
- Thrombocytopenia (platelet count <150,000/mm³), diagnosed in 7-12% of pregnancies, requires careful evaluation.
- Distinguishing physiological gestational thrombocytopenia from severe causes is critical for maternal and fetal outcomes.
Purpose of the Study:
- To highlight the importance of differentiating various causes of thrombocytopenia during pregnancy.
- To emphasize the need for timely and accurate diagnosis for appropriate management.
Main Methods:
- Review of common and severe causes of thrombocytopenia in pregnancy.
- Discussion of diagnostic challenges and clinical recognition of signs and symptoms.
Main Results:
- Most cases are mild gestational thrombocytopenia, but severe conditions like pre-eclampsia/HELLP syndrome, immune thrombocytopenia, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome can occur.
- Clinical presentation and severity of thrombocytopenia guide the diagnostic and management strategies.
Conclusions:
- Understanding the etiology and clinical signs of thrombocytopenia in pregnancy is essential for effective management.
- Treatment decisions are based on thrombocytopenia severity, cause, and gestational age to ensure optimal maternal and fetal health.
More Related Videos
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
1.1K
08:45Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
2.2K
Related Concept Videos
01:24Disorders of Hemostasis
1.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
01:29Venous Thrombosis III: Interprofessional Care
121
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
121
01:30Venous Thrombosis IV: Nursing Management
100
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
100
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
01:07Teratogenicity
3.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K
01:30Venous Thrombosis I: Introduction
128
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
128